7YQG image
Deposition Date 2022-08-06
Release Date 2023-06-07
Last Version Date 2023-11-29
Entry Detail
PDB ID:
7YQG
Keywords:
Title:
Functional and Structural Characterization of Norovirus GII.6 in Recognizing Histo-blood Group Antigens
Biological Source:
Source Organism:
Norovirus GII (Taxon ID: 122929)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.70 Å
R-Value Free:
0.17
R-Value Work:
0.14
R-Value Observed:
0.14
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:VP1
Gene (Uniprot):ORF2
Mutations:Q304P
Chain IDs:A, B
Chain Length:317
Number of Molecules:2
Biological Source:Norovirus GII
Ligand Molecules
Primary Citation
Functional and structural characterization of Norovirus GII.6 in recognizing histo-blood group antigens.
Virol Sin 38 56 65 (2023)
PMID: 36216242 DOI: 10.1016/j.virs.2022.09.010

Abstact

Noroviruses (NoVs) are the primary cause of acute gastroenteritis worldwide. Histo-blood group antigens (HBGAs) are receptors or attachment factors that affect the prevalence and host susceptibility of NoVs. GII.6 NoV is one of the predominant genotypes in humans, which recognizes the type ABO secretor of HBGAs. However, the structural basis of GII.6 NoV's interaction with HBGAs receptors remains elusive. In this study, we investigated the binding features of the GII.6 strain to HBGAs using saliva- and glycan-ELISA assays and characterized the molecular basis of the GII.6 virus that recognizes H disaccharide. We showed that the GII.6 ​P domain recognized some A and O secretor's saliva samples, most B secretor's saliva samples, and H disaccharide antigen, but did not bind non-secretors' saliva. Further, we determined the crystal structures of GII.6 and its complex with H disaccharides at 1.7 ​Å, revealing that the P domain of GII.6 shares the conventional binding interface and mode of GII HBGAs. Single residue mutations at the GII.6-H binding sites could inhibit the binding of GII.6 to HBGAs, demonstrating that the interaction residues were crucial in maintaining NoV-glycan integrity. Finally, structural and sequence analyses showed that the major residues of the GII.6-H interaction were conserved among NoVs in the GII genogroup. Taken together, our study characterized the functional and structural features of GII.6 that allow it to interact with HBGAs, and shed light on NoV evolution, epidemiology, and anti-viral drug development.

Legend

Protein

Chemical

Disease

Primary Citation of related structures